文献速递乳腺US

无 atypia 的良性乳腺乳头状瘤:手术切除与超声引导方向性真空辅助切除或超声随访的结局比较

Benign Breast Papilloma without Atypia: Outcomes of Surgical Excision versus US-guided Directional Vacuum-assisted Removal or US Follow-up.
PubMed 文献 · Radiology · 2019-08-20

本回顾性研究纳入2005年1月至2015年9月经超声引导空心针活检诊断为无 atypia 良性乳头状瘤的500例女性患者,比较手术切除(206例)、超声引导方向性真空辅助切除(233例)和超声随访无干预(61例)三组的临床与影像表现及恶性升级率,结果显示总升级率1.8%,三组间无显著差异(P=.80),倾向性评分匹配后手术组与真空辅助切除组升级率亦无显著差异(P=.48)。

要点

  • 无 atypia 良性乳头状瘤经超声引导空心针活检诊断后,总恶性升级率为1.8%(9/500)。
  • 手术组、超声引导方向性真空辅助切除组和超声随访组的升级率分别为1.9%、2.1%和0%,三组间无显著差异(P=.80)。
  • 超声引导方向性真空辅助切除后复发率为3.6%(6/166),随访24-65个月,复发灶再次手术均为良性。

核心结论

  • 无 atypia 良性乳头状瘤在超声引导方向性真空辅助切除和超声随访无干预后的低升级率、低复发率和低生长率提示,此类病变可采取更保守的管理而非手术切除。

研究设计与样本

  • 回顾性研究,纳入2005年1月至2015年9月连续500例经超声引导空心针活检诊断为无 atypia 良性乳头状瘤的女性患者,分为手术切除组(n=206)、超声引导方向性真空辅助切除组(n=233)和超声随访无干预超过2年组(n=61),比较三组临床与影像表现及恶性升级率,并行倾向性评分匹配比较手术组与真空辅助切除组的升级率。

诊断标准与关键数值

  • 总研究人群恶性升级率为1.8%(9/500,95%CI:0.9%,3.4%);手术组1.9%(4/206,95%CI:0.8%,4.9%);超声引导方向性真空辅助切除组2.1%(5/233,95%CI:0.9%,4.9%);超声随访无干预组0%(0/61,95%CI:0.0%,5.9%);三组比较P=.80。倾向性评分匹配后手术组升级率1.9%(3/151,95%CI:0.6%,5.6%),超声引导方向性真空辅助切除组3.3%(5/151,95%CI:1.4%,7.5%),P=.48。超声引导方向性真空辅助切除后随访24-65个月复发率3.6%(6/166),所有复发灶再次手术证实为良性。超声随访无干预组61个病灶中59个(97%)在平均43.3个月(范围25-130个月)随访期间大小稳定无生长。

临床应用与阅片要点

  • 作者认为,无 atypia 良性乳头状瘤经超声引导空心针活检诊断后,可采取更保守的管理而非手术切除。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Recent studies suggest that US-guided directional vacuum-assisted removal (DVAR) is a satisfactory alternative to surgery for benign papilloma of the breast and recommend discretionary diagnostic US follow-up without intervention. Purpose To compare the outcomes of benign papilloma without atypia diagnosed with core needle biopsy (CNB) in patients who underwent US-guided DVAR, US follow-up without intervention, or surgery. Materials and Methods This retrospective review included consecutive patients with benign papilloma without atypia diagnosed with US-guided CNB between January 2005 and September 2015. Five hundred female patients who underwent surgical excision (n = 206), US-guided DVAR (n = 233), or more than 2 years of US follow-up without intervention (n = 61) were included. The clinical and radiologic findings and cancer upgrade rate were compared among the three groups. Propensity score matching was performed for comparison of the upgrade rate in the surgery and US-guided DVAR groups. Results The mean patient age (±standard deviation) was 46.4 years ± 9.6. The upgrade rate to malignancy was 1.8% (nine of 500 patients; 95% confidence interval [CI]: 0.9%, 3.4%) in the total study population, 1.9% (four of 206 patients; 95% CI: 0.8%, 4.9%) after surgery, 2.1% (five of 233 patients; 95% CI: 0.9%, 4.9%) after US-guided DVAR, and 0% (0 of 61 patients; 95% CI: 0.0%, 5.9%) after US follow-up without intervention (P = .80); after propensity-score matching, the upgrade rate was 1.9% in the surgery group (three of 151 patients; 95% CI: 0.6%, 5.6%) and 3.3% in the US-guided DVAR group (five of 151 patients; 95% CI: 1.4%, 7.5%; P = .48). The recurrence rate after US-guided DVAR was 3.6% (six of 166 patients) during 24-65 months of follow-up; all recurrences were confirmed as benign at subsequent surgery. Fifty-nine of the 61 lesions in the group with US follow-up without intervention (97%) remained stable in size with no growth during a mean follow-up of 43.3 months (range, 25-130 months). Conclusion Low rates of upgrade, recurrence, and growth after US-guided directional vacuum-assisted removal and US follow-up without intervention suggest that benign papilloma without atypia can be managed more conservatively rather than undergoing surgical excision. © RSNA, 2019 Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Choi HY, Kim SM, Jang M, et al. Benign Breast Papilloma without Atypia: Outcomes of Surgical Excision versus US-guided Directional Vacuum-assisted Removal or US Follow-up. Radiology. 2019. PMID: 31429678. doi:10.1148/radiol.2019190096

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。